Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 850 of 6351
-
AI reads heart traces to find silent liver danger
Diagnosis CompletedThe overall objectives of this study are to determine the effectiveness of ACE 2.0 model in early detection of advanced liver fibrosis, and to determine the acceptance and barriers for use of an AI-enabled algorithm for prediction of liver disease in primary care.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
One infusion before surgery: could it cut transfusions?
Disease control CompletedAlthough there are multiple formulations of intravenous (IV) iron to choose from, a one-time dose of Monoferric would make it more feasible to integrate it in the perioperative pathway given an often-limited time between preoperative evaluation and surgery date. Furthermore, the …
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New pill may keep endometrial cancer at bay longer
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors versi…
Phase 3 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New hope for kids with tough tumors: drug combo trial launches
Disease control Recruiting nowThis trial is a multi-center, non-randomized, open-label Phase I/II study evaluating the feasibility and efficacy of vincristine, irinotecan, temozolomide, and atezolizumab in children with relapsed/refractory solid tumors.
Phase 1/2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill targets Hard-to-Treat cancers: early trial recruits 554 patients
Disease control Recruiting nowBDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability of S241656 as monotherapy and in combination with other anti-cancer therapies in participants with selected advanced ma…
Phase 1/2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug zanubrutinib takes on kidney disease in major trial
Disease control OngoingThe primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to evaluate the efficacy of zanubrutinib compared with tacrolimus as measured by complete remission rate, in participants with primary …
Phase 2/3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New device aims to save kidneys and lives in the ICU
Disease control Recruiting nowThis randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT)…
Sponsor: SeaStar Medical • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug spesolimab shows promise for painful skin condition
Disease control CompletedThis study is open to adults with moderate to severe hidradenitis suppurativa (HS). The purpose of this study is to find out whether a medicine called spesolimab helps people with HS. People who have previously taken specific medicines such as immunosuppressive biologics other th…
Phase 2/3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Stroke showdown: drug plus procedure vs. procedure alone for basilar artery blockage
Disease control CompletedCurrently, both intravenous thrombolysis (IVT) followed by endovascular treatment (EVT) and EVT alone are widely used for the treatment of acute ischemic stroke (AIS) caused by basilar artery occlusion (BAO) (AIS-BAO), but no direct comparison of their efficacy and safety was rep…
Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Heart bypass showdown: does using more arteries help women?
Disease control Recruiting nowThe central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major …
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Texting program aims to help smokers with HIV kick the habit
Disease control By invitation onlyThe intersection of smoking and HIV/AIDS poses a serious public health threat in Vietnam. Vietnam is dealing with these two challenges with parallel rather than integrated plans. Using a computer-tailored texting intervention, study investigators seek to promote the use of an und…
Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Electric suit aims to ease spasticity and boost balance in kids with cerebral palsy
Symptom relief CompletedCerebral Palsy (CP) is is estimated to be around 1.5-3 per live birth, with prenatal factors accounting for 75% of cases. CP appears in early childhood and persists with age and is characterized by permanent lesions or abnormalities affecting the immature brain. It mainly occurs …
Sponsor: Exoneural Network AB • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can an Hourglass-Shaped device relieve chest pain when arteries Aren't blocked?
Disease control OngoingTo demonstrate the feasibility and efficacy of the CS Reducer for the treatment of patients with ischaemia and non-obstructed coronary arteries (INOCA) and coronary microvascular dysfunction (CMD) and through a nested mechanistic substudy investigate the physiological responses i…
Sponsor: Imperial College London • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a new oral drug tame advanced breast cancer?
Disease control OngoingThis is a Phase 1 dose escalation and dose expansion phase I study to evaluate the safety, tolerability, pharmacokinetic profile and preliminary efficacy of RGT-419B as monotherapy in Chinese patients with HR+/HER2- advanced/metastatic breast cancer and other advanced solid tumor…
Phase 1 • Sponsor: Regor Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can one extra stitch in pancreatic surgery get patients eating again sooner?
Disease control CompletedThe goal of this clinical trial (REMBRANDT) is to evaluate the effectiveness of adding an extra connection (i.e. 'Braun anastomosis') after standard reconstruction in pancreatic head resection in reducing the incidence of delayed gastric emptying.
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can online brain training sharpen thinking in schizophrenia?
Disease control CompletedThe goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are: * To determine the clinical effectiveness of …
Sponsor: Douglas Mental Health University Institute • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a JAK inhibitor tame the immune attack in NMOSD?
Disease control OngoingNeuromyelitis Optica Spectrum Disorders (NMOSD) is associated with a pathological humoral immune response against the aquaporin-4(AQP-4) water channel. Baricitinib is an oral Janus kinase (JAK)1/JAK2 inhibitor that blocks the upregulated JAK-STAT pathway in patients with neuroimm…
Phase 1 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a 16-Hour fast be the key to better blood sugar in teens?
Disease control CompletedTo find the effectiveness of a diet plan (Time Limited Eating or TLE) on glycemic control, B-cell function, body fat, and body mass index (BMI) in adolescents with type 2 diabetes.
Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Needle vs. IV: which isatuximab method works best for myeloma?
Disease control CompletedThe trial aims to demonstrate the non-inferiority of subcutaneous to intravenous isatuximab administration in transplant-eligible patients with newly diagnosed multiple myeloma.
Phase 3 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New CAR T-Cell therapy targets tough lymphomas
Disease control Recruiting nowTo find the highest tolerable dose of JV-213 (a type of autologous CAR T cell therapy) that can be given to patients who have B-cell lymphoma that is relapsed or refractory.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC